Tap into a Global Network of Leading Renal Drug Developers, Forge Strategic Partnerships, & Stake your Claim in CKD Renown
The CKD market size is projected to reach a whopping $110bn by 2030, with headlines from the $800M Novartis-Regulus acquisition and Renasant Bio raising $55M in seed funding for ADPKD underscoring the growing priority for pharma and biotech on renal R&D. Â
Leading pharma and biotech are looking for excellence in model providers, CRO expertise, imaging and diagnostics, CDMOs, proteomic and metabolomics vendors to give them an edge on the competition – that’s where you come in.Â
What To Expect
Cultivate High-Value Connections & Opportunities: Maximize your exposure to industry leaders through dedicated networking sessions and 1-2-1 meetings. Build meaningful relationships that translate into new business leads across the CKD landscapeÂ
Keep Informed of Market Shifts: As the leading forum for CKD drug development, this summit is the ideal place to stay updated on emerging trends, novel therapies, and new approaches in clinical trial design. Use this opportunity to stay ahead of the curve in the evolving kidney disease landscape.Â
Differentiate Your Product & Become the Partner of Choice: Distinguish your offerings by highlighting your unique capabilities and services to position your company as the strategic partner of choice for CKD drug developers, standing out among other model providers, imaging solutions, and CROs with a strong track record in kidney disease research.Â
Key Services & Solutions
So what types of companies can benefit most from a partnership with the 8th CKD Summit Series?
Top Solutions Needed:
Clinical CROs with Specialized Expertise in Design and Execution of Clinical Trials from Across Rare & Common Kidney Disorders
Preclinical Models with Proven Translatability to Accurately Predict Human Renal Outcomes and Support Early-Stage Drug Development
Drug Discovery CROs Specializing in Uncovering Novel Targets for Renal Diseases and Advancing Early-Stage Drug Development
Advanced Imaging & Monitoring Technologies to Precisely Monitor Changes in Renal Function
Or... Are You a Drug Developer Looking to Strengthen Your Position in the Renal Space?
Non-Invasive Biomarkers for Earlier Diagnosis, Patient Stratification, & Monitoring of Renal Diseases
Recognize yourself and your business priorities in this description? With speaking and exhibitor inventory already running low, don’t hesitate to REACH OUT for more information on partnership packages, attendee lists and create a bespoke package that aligns with your goals together.Â
Or CLICK HERE to see who’s already partnered for 2026 turn the page… Â
Hear What Our Past Sponsors Have to Say
The Hanson Wade staff were so helpful during this conference, from instruction before to setup during and intros to other vendors and attendees, making it run so smoothly! Speed networking is always a great time, and the conference layout and speakers were fantastic!
Associate Director, Business Development, George ClinicalÂ
Interesting to hear the problems and opportunities for drug development in CKD, great to network with key drug developers in the space
Senior Scientific Advisor, Antaros MedicalÂ
I found the high-quality presentations and meeting professionals in CKD extremely valuable
Clinical Assistant, Organ Health, NateraÂ
Varied program and delegate list - was nicely balanced between pre-clinical and clinical focused groups
Director, FibroFindÂ
Great representation of biopharmas in renal space
Head of Business Development & Licensing, Enyo PharmaÂ
Audience Composition
Company Type
Attendee Seniority
Attending Companies Include
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
William Hobson-Corbett
Senior Partnerships DirectorÂ